The U.S. Centers for Disease Control and Prevention are soliciting grant applications to support enhanced surveillance for new vaccine preventable diseases.
The effort will fund a network of pediatric medical institutions conducting prospective, active surveillance for acute gastroenteritis (AGE) and acute respiratory illnesses (ARI) in inpatient and emergency department clinical settings, and among asymptomatic healthy controls.
Funded activities for this award will include:
- Provision of a US pediatric vaccine-preventable disease surveillance system
- Evaluations of vaccine effectiveness for licensed vaccines including rotavirus and influenza
- Burden and natural history of disease for pathogens having upcoming and/or new vaccines
- Pediatric infectious disease transmission dynamics
- Informing vaccination/therapeutic policy and development
- Vaccine impacts for targeted and vulnerable populations
- Socioeconomic and microbiological environments relevant to these public health interventions
A second purpose of this announcement is to prospectively follow a birth cohort to the second birthday to incorporate a natural history study of pathogens and immunologic factors related to symptomatic and asymptomatic infection in US infants. This second activity will be a separate Optional Component of the application, independently scored, that will be awarded to an applicant that has been competitively awarded a Core Component award.
The funding is open to state and local governments, academic, not-for-profits, and Federally Funded Research and Development Centers (FFRDCs).
Further details are available via Funding Opportunity Number: CDC-RFA-IP-16-004. The application deadline is Jan 15, 2016.
